| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c91bbf0395db010b4806f50d808c4e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
1978-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1981-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f27161fc949293bd9ec7ee2536305ec8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9bd313d852a9f2625cfac050363f2bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0fd66d0b91f1497968cf35f5c77c271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf2f9ecd67e24e7023550af453f1406b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41e04ade255a6d664a98b2011345b48f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a23320970dc771aadfe9e237ca30b387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fec1d80a97c9d5c70ae387b818773a8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6609c4288b65d791c602950e4ae5de95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1baf7d1022cd370671106035361f8b2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcdcb3e6e62e61b30399bdaeea29a986 |
| publicationDate |
1981-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-1100495-A |
| titleOfInvention |
Process for the preparation of alkaloids of the leurosine type |
| abstract |
ABSTRACT OF THE DISCLOSURE The invention relates to a new process for the preparation of alkaloids of the leurosine type having the general formula I (I) and the acid addition salts thereof. In the formula I R represents a hydrogen atom or a methyl group. The compounds prepared according to the invention are known compounds showing cytostatic activity. |
| priorityDate |
1977-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |